Literature DB >> 8576128

Sp1 mediates glucose activation of the acetyl-CoA carboxylase promoter.

S Daniel1, K H Kim.   

Abstract

Acetyl-CoA carboxylase (ACC), the rate-limiting enzyme in the biosynthesis of fatty acids, is induced in the presence of high glucose levels. The ACC gene contains two promoters: promoter I (PI) expression is inducible under lipogenic conditions, while promoter II (PII) expression, even though constitutively expressed in all tissues, is also controlled under various physiological conditions. Examination of the expression pattern of a series of deletion constructs of PII showed that the region from -340 to -249 was essential for ACC induction. In addition, by electrophoretic mobility shift assays, supershift assays, and DNase I footprinting studies, we have detected the binding of the transcription factor Sp1 at the two GC-rich sequences located within the -340 to -249 region of promoter II. Mutations at the GC-rich sequences prevented binding of Sp1, and the induction of the PII promoter was no longer observed. Cotransfection studies, in Drosophila Schneider SL2 cells, with the Sp1 expression vector and PII-CAT constructs, have further confirmed the activation of promoter II by Sp1. In addition, we have identified Sp3, another member of the Sp1 family of transcription factors, as a second factor that can bind to the glucose response elements of PII.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8576128     DOI: 10.1074/jbc.271.3.1385

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Spot 14 protein interacts and co-operates with chicken ovalbumin upstream promoter-transcription factor 1 in the transcription of the L-type pyruvate kinase gene through a specificity protein 1 (Sp1) binding site.

Authors:  E Compe; G de Sousa; K François; R Roche; R Rahmani; J Torresani; M Raymondjean; R Planells
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

2.  Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription.

Authors:  S B Kennett; A J Udvadia; J M Horowitz
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

3.  Polyunsaturated fatty acids inhibit fatty acid synthase and spot-14-protein gene expression in cultured rat hepatocytes by a peroxidative mechanism.

Authors:  M Foretz; F Foufelle; P Ferré
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

4.  Role of sp transcription factors in the regulation of cancer cell metabolism.

Authors:  Michael C Archer
Journal:  Genes Cancer       Date:  2011-07

5.  AKT Ser/Thr kinase increases V-ATPase-dependent lysosomal acidification in response to amino acid starvation in mammalian cells.

Authors:  Michael P Collins; Laura A Stransky; Michael Forgac
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

6.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation.

Authors:  X L Du; D Edelstein; L Rossetti; I G Fantus; H Goldberg; F Ziyadeh; J Wu; M Brownlee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

7.  Sterol regulatory element binding protein and dietary lipid regulation of fatty acid synthesis in the mammary epithelium.

Authors:  Michael C Rudolph; Jenifer Monks; Valerie Burns; Meridee Phistry; Russell Marians; Monica R Foote; Dale E Bauman; Steven M Anderson; Margaret C Neville
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-24       Impact factor: 4.310

8.  High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.

Authors:  R Babaei-Jadidi; N Karachalias; C Kupich; N Ahmed; P J Thornalley
Journal:  Diabetologia       Date:  2004-12-11       Impact factor: 10.122

9.  Regulation of mammalian pyruvate dehydrogenase alpha subunit gene expression by glucose in HepG2 cells.

Authors:  J Tan; H S Yang; M S Patel
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

10.  Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.

Authors:  Daniela Gasperíková; Nicolas D Tribble; Juraj Staník; Miroslava Hucková; Nadezda Misovicová; Martijn van de Bunt; Lucia Valentínová; Beryl A Barrow; L'ubomir Barák; Radoslav Dobránsky; Eva Bereczková; Jozef Michálek; Kate Wicks; Kevin Colclough; Julian C Knight; Sian Ellard; Iwar Klimes; Anna L Gloyn
Journal:  Diabetes       Date:  2009-05-01       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.